tiprankstipranks
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Income Statement

Compare
1,258 Followers

Entero Therapeutics Income Statement

Last quarter (Q3 2024), Entero Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Entero Therapeutics's net income was $-2.58M. See Entero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -29.27K$ -106.21K$ -537.40K$ -571.14K$ -976.98K
Operating Expenses
$ 15.77M$ 12.68M$ 56.70M$ 26.43M$ 14.74K
Depreciation and Amortization
$ 29.27K$ 29.27K$ 542.25K$ 565.35K-
EBITDA
$ -15.74M$ -14.51M$ -57.99M$ -26.26M$ -13.77M
Operating Income
$ -15.77M$ -12.68M$ -59.06M$ -26.43M-
Other Income/Expenses
$ -24.16K$ -1.95M$ -1.83M$ -6.24M$ -433.94K
Pretax Income
$ -15.79M$ -14.63M$ -58.54M$ -32.67M-
Net Income
$ -15.79M$ -14.63M$ -58.54M$ -32.67M$ -15.18M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -47.88$ -416.93$ -39.77K$ -61.64K$ -28.43K
Diluted EPS
$ -47.88$ -416.93$ -39.77K$ -61.64K$ -28.43K
Weighted Average Shares Outstanding
336.34K 35.91K---
Weighted Average Shares Outstanding (Diluted)
336.34K 35.91K---
Currency in USD

Entero Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis